undamentalytics Newsletter

Scynexis Inc balance sheet

At the end of fiscal 2025, Scynexis Inc had total assets of $59.0m, total liabilities of $9.7m and shareholders' equity of $49.4m. It held $21.3m in cash against $0 of debt: net cash of $21.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Scynexis Inc: balance sheet, annual
Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1324736111142931044634162110
Receivables11—————0120———
Inventory———————0010———
Total current assets34048594551529810979102724056
Total assets1240496046535710312088128915975
Accounts payable20124475867523
Deferred revenue (current)0000000——01200
Total current liabilities1857410611261418162466
Short-term debt150—040——0—————
Long-term debt——01410150—34—————
Total debt1500141515003535—000
Total liabilities3367252422448079855536108
Shareholders' equity−1083342352131132341373554967
Non-controlling interests and other (assets − liabilities − equity)87—————————————
Net debt (negative = net cash)14−32−47−2134−42−93−69−11−34−16−21−10
Shares outstanding——————10m—29m———54m10m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CELU vs SCYXCTMX vs SCYXPRQR vs SCYX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Scynexis Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Scynexis Inc.